The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients.
The GSTA1 polymorphism and cyclophosphamide therapy outcomes in lupus nephritis patients.
复制标题
DOI：
10.1016/j.clim.2015.07.010
复制
发表时间：
2015-10
影响因子：
8.6
通讯作者：
Hong-Na Wang;Xiaoye Zhu;Ying Zhu;Qionghong Xie;Lingyun Lai;Miao Zhao;Yuanguo Chen;Jun Xue;C. Hao;Yong Gu;Shantan Lin
中科院分区：
文献类型：
--
作者：
Hong-Na Wang;Xiaoye Zhu;Ying Zhu;Qionghong Xie;Lingyun Lai;Miao Zhao;Yuanguo Chen;Jun Xue;C. Hao;Yong Gu;Shantan Lin
